Effects of N-ethylmaleimide on 5-hydroxytryptamine Transport and Sodium Content in Rabbit Platelets

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1989 Aug 1

PMID 2790384

Citations 4

Authors

R Wolfel

T Halbrugge

K H Graefe

Affiliations

Soon will be listed here.

Abstract

1. The present study analysed the mechanism underlying the inhibitory action of N-ethylmaleimide (NEM) on the 5-hydroxytryptamine (5-HT) uptake by blood platelets. 2. Rabbit platelets suspended in protein-free buffer were first preincubated for 45 min in the absence and presence of NEM (20 to 160 microM) or ouabain (0.5-2.0 microM) and then either analysed for their Na+ and K+ content or incubated (15s) with various concentrations of [3H]-5-HT (0.13-4.03 microM) to determine Km and Vmax for 5-HT uptake. 3. Both NEM and ouabain produced concentration-dependent decreases in Vmax with IC50 values of 52 and 0.58 microM, respectively. Neither drug changed Km significantly. 4. Both NEM and ouabain increased the Na+ and decreased the K+ content of platelets in a concentration-dependent manner. 5. There was a linear correlation between Vmax (expressed in % of control) and the reciprocal cellular Na+ content, with the results for both drugs falling onto one and the same regression line (r = 0.992; n = 8). This regression showed that an increase in Na+ content by 69% sufficed to reduce Vmax by 50%. 6. At concentrations that reduced 5-HT uptake by about 60%, neither NEM nor ouabain altered the potency of imipramine for inhibition of 5-HT uptake. 7. Hence, NEM inhibits 5-HT transport by inhibiting the Na+/K+-ATPase and not by a direct interaction with the 5-HT carrier. The consequential increase in the intracellular Na+ concentration reduces the transmembrane Na+ gradient and, therefore, hinders 5-HT inward transport. This action of the drug does not affect the ability of the carrier to bind 5-HT or imipramine.

Citing Articles

Restoration of tryptophan hydroxylase functions and serotonin content in the Atlantic croaker hypothalamus by antioxidant treatment during hypoxic stress.

Rahman M, Thomas P Front Neurosci. 2014; 8:130.

PMID: 24910592 PMC: 4038761. DOI: 10.3389/fnins.2014.00130.

N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.

Wenge B, Bonisch H Naunyn Schmiedebergs Arch Pharmacol. 2008; 377(3):255-65.

PMID: 18357440 DOI: 10.1007/s00210-008-0272-0.

Creatine transporters: a reappraisal.

Speer O, Neukomm L, Murphy R, Zanolla E, Schlattner U, Henry H Mol Cell Biochem. 2004; 256-257(1-2):407-24.

PMID: 14977199 DOI: 10.1023/b:mcbi.0000009886.98508.e7.

Prejunctional alpha 2-adrenoceptors in mouse atria function through G-proteins which are sensitive to N-ethylmaleimide, but not pertussis toxin.

Murphy T, Foucart S, Majewski H Br J Pharmacol. 1992; 106(4):871-6.

PMID: 1356569 PMC: 1907645. DOI: 10.1111/j.1476-5381.1992.tb14427.x.

References

Meyerson L, Ieni J, Wennogle L . Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets. J Neurochem. 1987; 48(2):560-5. DOI: 10.1111/j.1471-4159.1987.tb04129.x. View

Marcusson J, Backstrom I, Ross S . Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site. Mol Pharmacol. 1986; 30(2):121-8. View

Marcusson J, Tiger G . [3H]imipramine binding of protein nature in human platelets: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors. J Neurochem. 1988; 50(4):1032-6. DOI: 10.1111/j.1471-4159.1988.tb10569.x. View

Humphreys C, Levin J, Rudnick G . Antidepressant binding to the porcine and human platelet serotonin transporters. Mol Pharmacol. 1988; 33(6):657-63. View

Schomig E, Bonisch H . Inhibition of neuronal noradrenaline uptake (uptake1) and desipramine binding by N-ethylmaleimide (NEM). Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(6):633-6. DOI: 10.1007/BF00175788. View

Born G, Juengjaroen K, Michal F . Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues. Br J Pharmacol. 1972; 44(1):117-39. PMC: 1665693. DOI: 10.1111/j.1476-5381.1972.tb07244.x. View

Sneddon J . Sodium-dependent accumulation of 5-hydroxytryptamine by rat blood platelets. Br J Pharmacol. 1969; 37(3):680-8. PMC: 1703717. DOI: 10.1111/j.1476-5381.1969.tb08506.x. View

Wolfel R, Bohm W, Halbrugge T, Bonisch H, Graefe K . On the 5-hydroxytryptamine transport across the plasma membrane of rabbit platelets and its inhibition by imipramine. Naunyn Schmiedebergs Arch Pharmacol. 1988; 338(1):1-8. DOI: 10.1007/BF00168804. View

Sneddon J . Relationship between internal Na + -K + and the accumulation of 14 C-5-hydroxytryptamine by rat platelets. Br J Pharmacol. 1971; 43(4):834-44. PMC: 1665702. DOI: 10.1111/j.1476-5381.1971.tb07220.x. View

10.

Tuomisto J . A new modification for studying 5-HT uptake by blood platelets: a re-evaluation of tricyclic antidepressants as uptake inhibitors. J Pharm Pharmacol. 1974; 26(2):92-100. DOI: 10.1111/j.2042-7158.1974.tb09231.x. View

11.

Rudnick G . Active transport of 5-hydroxytryptamine by plasma membrane vesicles isolated from human blood platelets. J Biol Chem. 1977; 252(7):2170-4. View

12.

Akera T, BRODY T . The role of Na+,K+-ATPase in the inotropic action of digitalis. Pharmacol Rev. 1977; 29(3):187-220. View

13.

Talvenheimo J, Nelson P, Rudnick G . Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport. J Biol Chem. 1979; 254(11):4631-5. View

14.

Raisman R, Briley M, Langer S . Specific tricyclic antidepressant binding sites in rat brain. Nature. 1979; 281(5727):148-50. DOI: 10.1038/281148a0. View

15.

Briley M, Raisman R, Langer S . Human platelets possess high-affinity binding sites for 3H-imipramine. Eur J Pharmacol. 1979; 58(3):347-8. DOI: 10.1016/0014-2999(79)90489-8. View

16.

Rehavi M, Paul S, Skolnick P, Goodwin F . Demonstration of specific high affinity binding sites for [3H] imipramine in human brain. Life Sci. 1980; 26(26):2273-9. DOI: 10.1016/0024-3205(80)90213-1. View

17.

Langer S, Moret C, Raisman R, Dubocovich M, Briley M . High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine. Science. 1980; 210(4474):1133-5. DOI: 10.1126/science.7444441. View

18.

Langer S, Zarifian E, Briley M, Raisman R, Sechter D . High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders. Life Sci. 1981; 29(3):211-20. DOI: 10.1016/0024-3205(81)90236-8. View

19.

Wennogle L, Meyerson L . Serotonin modulates the dissociation of [3H]imipramine from human platelet recognition sites. Eur J Pharmacol. 1982; 86(2):303-7. DOI: 10.1016/0014-2999(82)90333-8. View

20.

Sette M, Briley M, Langer S . Complex inhibition of [3H]imipramine binding by serotonin and nontricyclic serotonin uptake blockers. J Neurochem. 1983; 40(3):622-8. DOI: 10.1111/j.1471-4159.1983.tb08026.x. View